カテゴリー： 世界, 医療/バイオ, QYResearch

オラパリブ薬の世界市場インサイト・予測（～2028年）

【英語タイトル】Global Olaparib Drugs Market Insights, Forecast to 2028

QYResearchが出版した調査資料（QY22JLX10431）・商品コード：QY22JLX10431
・発行会社（調査会社）：QYResearch
・発行日：2022年7月（※2025年版があります。お問い合わせください。）
・ページ数：70
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD4,900 ⇒換算￥744,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD7,350 ⇒換算￥1,117,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD9,800 ⇒換算￥1,489,600見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

COVID-19のパンデミックにより、オラパリブ薬のグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にオラパリブ薬の世界市場のxxx％を占める「100mg」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
オラパリブ薬の中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのオラパリブ薬市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

オラパリブ薬のグローバル主要企業には、AstraZeneca、MSD、Everest Pharmaceuticalsなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

オラパリブ薬市場は、種類と用途によって区分されます。世界のオラパリブ薬市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
100mg、150mg

【用途別セグメント】
病院、クリニック、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- オラパリブ薬製品概要
- 種類別市場（100mg、150mg）
- 用途別市場（病院、クリニック、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界のオラパリブ薬販売量予測2017-2028
- 世界のオラパリブ薬売上予測2017-2028
- オラパリブ薬の地域別販売量
- オラパリブ薬の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別オラパリブ薬販売量
- 主要メーカー別オラパリブ薬売上
- 主要メーカー別オラパリブ薬価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（100mg、150mg）
- オラパリブ薬の種類別販売量
- オラパリブ薬の種類別売上
- オラパリブ薬の種類別価格
・用途別市場規模（病院、クリニック、その他）
- オラパリブ薬の用途別販売量
- オラパリブ薬の用途別売上
- オラパリブ薬の用途別価格
・北米市場
- 北米のオラパリブ薬市場規模（種類別、用途別）
- 主要国別のオラパリブ薬市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパのオラパリブ薬市場規模（種類別、用途別）
- 主要国別のオラパリブ薬市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋のオラパリブ薬市場規模（種類別、用途別）
- 主要国別のオラパリブ薬市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米のオラパリブ薬市場規模（種類別、用途別）
- 主要国別のオラパリブ薬市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカのオラパリブ薬市場規模（種類別、用途別）
- 主要国別のオラパリブ薬市場規模（トルコ、サウジアラビア）
・企業情報
AstraZeneca、MSD、Everest Pharmaceuticals
・産業チェーン及び販売チャネル分析
- オラパリブ薬の産業チェーン分析
- オラパリブ薬の原材料
- オラパリブ薬の生産プロセス
- オラパリブ薬の販売及びマーケティング
- オラパリブ薬の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- オラパリブ薬の産業動向
- オラパリブ薬のマーケットドライバー
- オラパリブ薬の課題
- オラパリブ薬の阻害要因
・主な調査結果

Market Analysis and Insights: Global Olaparib Drugs Market
Due to the COVID-19 pandemic, the global Olaparib Drugs market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, 100 mg accounting for % of the Olaparib Drugs global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Olaparib Drugs market size is valued at US$ million in 2021, while the US and Europe Olaparib Drugs are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Olaparib Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Olaparib Drugs include AstraZeneca, MSD and Everest Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Olaparib Drugs Scope and Segment
Olaparib Drugs market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Olaparib Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
100 mg
150 mg
Segment by Application
Hospital
Clinic
Others
By Company
AstraZeneca
MSD
Everest Pharmaceuticals
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

❖ レポートの目次 ❖

1 Study Coverage
1.1 Olaparib Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Olaparib Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 100 mg
1.2.3 150 mg
1.3 Market by Application
1.3.1 Global Olaparib Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Olaparib Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Olaparib Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Olaparib Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Olaparib Drugs Sales by Region
2.4.1 Global Olaparib Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Olaparib Drugs by Region (2023-2028)
2.5 Global Olaparib Drugs Revenue by Region
2.5.1 Global Olaparib Drugs Revenue by Region (2017-2022)
2.5.2 Global Olaparib Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Olaparib Drugs Sales by Manufacturers
3.1.1 Global Top Olaparib Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Olaparib Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Olaparib Drugs in 2021
3.2 Global Olaparib Drugs Revenue by Manufacturers
3.2.1 Global Olaparib Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Olaparib Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Olaparib Drugs Revenue in 2021
3.3 Global Olaparib Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Olaparib Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Olaparib Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Olaparib Drugs Sales by Type
4.1.1 Global Olaparib Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Olaparib Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Olaparib Drugs Sales Market Share by Type (2017-2028)
4.2 Global Olaparib Drugs Revenue by Type
4.2.1 Global Olaparib Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Olaparib Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Olaparib Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Olaparib Drugs Price by Type
4.3.1 Global Olaparib Drugs Price by Type (2017-2022)
4.3.2 Global Olaparib Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Olaparib Drugs Sales by Application
5.1.1 Global Olaparib Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Olaparib Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Olaparib Drugs Sales Market Share by Application (2017-2028)
5.2 Global Olaparib Drugs Revenue by Application
5.2.1 Global Olaparib Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Olaparib Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Olaparib Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Olaparib Drugs Price by Application
5.3.1 Global Olaparib Drugs Price by Application (2017-2022)
5.3.2 Global Olaparib Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Olaparib Drugs Market Size by Type
6.1.1 North America Olaparib Drugs Sales by Type (2017-2028)
6.1.2 North America Olaparib Drugs Revenue by Type (2017-2028)
6.2 North America Olaparib Drugs Market Size by Application
6.2.1 North America Olaparib Drugs Sales by Application (2017-2028)
6.2.2 North America Olaparib Drugs Revenue by Application (2017-2028)
6.3 North America Olaparib Drugs Market Size by Country
6.3.1 North America Olaparib Drugs Sales by Country (2017-2028)
6.3.2 North America Olaparib Drugs Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Olaparib Drugs Market Size by Type
7.1.1 Europe Olaparib Drugs Sales by Type (2017-2028)
7.1.2 Europe Olaparib Drugs Revenue by Type (2017-2028)
7.2 Europe Olaparib Drugs Market Size by Application
7.2.1 Europe Olaparib Drugs Sales by Application (2017-2028)
7.2.2 Europe Olaparib Drugs Revenue by Application (2017-2028)
7.3 Europe Olaparib Drugs Market Size by Country
7.3.1 Europe Olaparib Drugs Sales by Country (2017-2028)
7.3.2 Europe Olaparib Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Olaparib Drugs Market Size by Type
8.1.1 Asia Pacific Olaparib Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Olaparib Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Olaparib Drugs Market Size by Application
8.2.1 Asia Pacific Olaparib Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Olaparib Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Olaparib Drugs Market Size by Region
8.3.1 Asia Pacific Olaparib Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Olaparib Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Olaparib Drugs Market Size by Type
9.1.1 Latin America Olaparib Drugs Sales by Type (2017-2028)
9.1.2 Latin America Olaparib Drugs Revenue by Type (2017-2028)
9.2 Latin America Olaparib Drugs Market Size by Application
9.2.1 Latin America Olaparib Drugs Sales by Application (2017-2028)
9.2.2 Latin America Olaparib Drugs Revenue by Application (2017-2028)
9.3 Latin America Olaparib Drugs Market Size by Country
9.3.1 Latin America Olaparib Drugs Sales by Country (2017-2028)
9.3.2 Latin America Olaparib Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Olaparib Drugs Market Size by Type
10.1.1 Middle East and Africa Olaparib Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Olaparib Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Olaparib Drugs Market Size by Application
10.2.1 Middle East and Africa Olaparib Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Olaparib Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Olaparib Drugs Market Size by Country
10.3.1 Middle East and Africa Olaparib Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Olaparib Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Corporation Information
11.1.2 AstraZeneca Overview
11.1.3 AstraZeneca Olaparib Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 AstraZeneca Olaparib Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 AstraZeneca Recent Developments
11.2 MSD
11.2.1 MSD Corporation Information
11.2.2 MSD Overview
11.2.3 MSD Olaparib Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 MSD Olaparib Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 MSD Recent Developments
11.3 Everest Pharmaceuticals
11.3.1 Everest Pharmaceuticals Corporation Information
11.3.2 Everest Pharmaceuticals Overview
11.3.3 Everest Pharmaceuticals Olaparib Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Everest Pharmaceuticals Olaparib Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Everest Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Olaparib Drugs Industry Chain Analysis
12.2 Olaparib Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Olaparib Drugs Production Mode & Process
12.4 Olaparib Drugs Sales and Marketing
12.4.1 Olaparib Drugs Sales Channels
12.4.2 Olaparib Drugs Distributors
12.5 Olaparib Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Olaparib Drugs Industry Trends
13.2 Olaparib Drugs Market Drivers
13.3 Olaparib Drugs Market Challenges
13.4 Olaparib Drugs Market Restraints
14 Key Findings in The Global Olaparib Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Olaparib Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of 100 mg
Table 3. Major Manufacturers of 150 mg
Table 4. Global Olaparib Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Olaparib Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Olaparib Drugs Sales by Region (2017-2022) & (K Pcs)
Table 7. Global Olaparib Drugs Sales Market Share by Region (2017-2022)
Table 8. Global Olaparib Drugs Sales by Region (2023-2028) & (K Pcs)
Table 9. Global Olaparib Drugs Sales Market Share by Region (2023-2028)
Table 10. Global Olaparib Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Olaparib Drugs Revenue Market Share by Region (2017-2022)
Table 12. Global Olaparib Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Olaparib Drugs Revenue Market Share by Region (2023-2028)
Table 14. Global Olaparib Drugs Sales by Manufacturers (2017-2022) & (K Pcs)
Table 15. Global Olaparib Drugs Sales Share by Manufacturers (2017-2022)
Table 16. Global Olaparib Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Olaparib Drugs Revenue Share by Manufacturers (2017-2022)
Table 18. Olaparib Drugs Price by Manufacturers (2017-2022) &(US$/Pcs)
Table 19. Global Olaparib Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Olaparib Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Olaparib Drugs as of 2021)
Table 21. Olaparib Drugs Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Olaparib Drugs Product Offered
Table 23. Date of Manufacturers Enter into Olaparib Drugs Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Olaparib Drugs Sales by Type (2017-2022) & (K Pcs)
Table 26. Global Olaparib Drugs Sales by Type (2023-2028) & (K Pcs)
Table 27. Global Olaparib Drugs Sales Share by Type (2017-2022)
Table 28. Global Olaparib Drugs Sales Share by Type (2023-2028)
Table 29. Global Olaparib Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Olaparib Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Olaparib Drugs Revenue Share by Type (2017-2022)
Table 32. Global Olaparib Drugs Revenue Share by Type (2023-2028)
Table 33. Olaparib Drugs Price by Type (2017-2022) & (US$/Pcs)
Table 34. Global Olaparib Drugs Price Forecast by Type (2023-2028) & (US$/Pcs)
Table 35. Global Olaparib Drugs Sales by Application (2017-2022) & (K Pcs)
Table 36. Global Olaparib Drugs Sales by Application (2023-2028) & (K Pcs)
Table 37. Global Olaparib Drugs Sales Share by Application (2017-2022)
Table 38. Global Olaparib Drugs Sales Share by Application (2023-2028)
Table 39. Global Olaparib Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Olaparib Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Olaparib Drugs Revenue Share by Application (2017-2022)
Table 42. Global Olaparib Drugs Revenue Share by Application (2023-2028)
Table 43. Olaparib Drugs Price by Application (2017-2022) & (US$/Pcs)
Table 44. Global Olaparib Drugs Price Forecast by Application (2023-2028) & (US$/Pcs)
Table 45. North America Olaparib Drugs Sales by Type (2017-2022) & (K Pcs)
Table 46. North America Olaparib Drugs Sales by Type (2023-2028) & (K Pcs)
Table 47. North America Olaparib Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Olaparib Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Olaparib Drugs Sales by Application (2017-2022) & (K Pcs)
Table 50. North America Olaparib Drugs Sales by Application (2023-2028) & (K Pcs)
Table 51. North America Olaparib Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Olaparib Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Olaparib Drugs Sales by Country (2017-2022) & (K Pcs)
Table 54. North America Olaparib Drugs Sales by Country (2023-2028) & (K Pcs)
Table 55. North America Olaparib Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Olaparib Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Olaparib Drugs Sales by Type (2017-2022) & (K Pcs)
Table 58. Europe Olaparib Drugs Sales by Type (2023-2028) & (K Pcs)
Table 59. Europe Olaparib Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Olaparib Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Olaparib Drugs Sales by Application (2017-2022) & (K Pcs)
Table 62. Europe Olaparib Drugs Sales by Application (2023-2028) & (K Pcs)
Table 63. Europe Olaparib Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Olaparib Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Olaparib Drugs Sales by Country (2017-2022) & (K Pcs)
Table 66. Europe Olaparib Drugs Sales by Country (2023-2028) & (K Pcs)
Table 67. Europe Olaparib Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Olaparib Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Olaparib Drugs Sales by Type (2017-2022) & (K Pcs)
Table 70. Asia Pacific Olaparib Drugs Sales by Type (2023-2028) & (K Pcs)
Table 71. Asia Pacific Olaparib Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Olaparib Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Olaparib Drugs Sales by Application (2017-2022) & (K Pcs)
Table 74. Asia Pacific Olaparib Drugs Sales by Application (2023-2028) & (K Pcs)
Table 75. Asia Pacific Olaparib Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Olaparib Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Olaparib Drugs Sales by Region (2017-2022) & (K Pcs)
Table 78. Asia Pacific Olaparib Drugs Sales by Region (2023-2028) & (K Pcs)
Table 79. Asia Pacific Olaparib Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Olaparib Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Olaparib Drugs Sales by Type (2017-2022) & (K Pcs)
Table 82. Latin America Olaparib Drugs Sales by Type (2023-2028) & (K Pcs)
Table 83. Latin America Olaparib Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Olaparib Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Olaparib Drugs Sales by Application (2017-2022) & (K Pcs)
Table 86. Latin America Olaparib Drugs Sales by Application (2023-2028) & (K Pcs)
Table 87. Latin America Olaparib Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Olaparib Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Olaparib Drugs Sales by Country (2017-2022) & (K Pcs)
Table 90. Latin America Olaparib Drugs Sales by Country (2023-2028) & (K Pcs)
Table 91. Latin America Olaparib Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Olaparib Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Olaparib Drugs Sales by Type (2017-2022) & (K Pcs)
Table 94. Middle East and Africa Olaparib Drugs Sales by Type (2023-2028) & (K Pcs)
Table 95. Middle East and Africa Olaparib Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Olaparib Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Olaparib Drugs Sales by Application (2017-2022) & (K Pcs)
Table 98. Middle East and Africa Olaparib Drugs Sales by Application (2023-2028) & (K Pcs)
Table 99. Middle East and Africa Olaparib Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Olaparib Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Olaparib Drugs Sales by Country (2017-2022) & (K Pcs)
Table 102. Middle East and Africa Olaparib Drugs Sales by Country (2023-2028) & (K Pcs)
Table 103. Middle East and Africa Olaparib Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Olaparib Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 105. AstraZeneca Corporation Information
Table 106. AstraZeneca Description and Major Businesses
Table 107. AstraZeneca Olaparib Drugs Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 108. AstraZeneca Olaparib Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. AstraZeneca Recent Developments
Table 110. MSD Corporation Information
Table 111. MSD Description and Major Businesses
Table 112. MSD Olaparib Drugs Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 113. MSD Olaparib Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. MSD Recent Developments
Table 115. Everest Pharmaceuticals Corporation Information
Table 116. Everest Pharmaceuticals Description and Major Businesses
Table 117. Everest Pharmaceuticals Olaparib Drugs Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 118. Everest Pharmaceuticals Olaparib Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Everest Pharmaceuticals Recent Developments
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Olaparib Drugs Distributors List
Table 123. Olaparib Drugs Customers List
Table 124. Olaparib Drugs Market Trends
Table 125. Olaparib Drugs Market Drivers
Table 126. Olaparib Drugs Market Challenges
Table 127. Olaparib Drugs Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Olaparib Drugs Product Picture
Figure 3. Global Olaparib Drugs Market Share by Type in 2021 & 2028
Figure 3. 100 mg Product Picture
Figure 4. 150 mg Product Picture
Figure 5. Global Olaparib Drugs Market Share by Application in 2021 & 2028
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Others
Figure 9. Olaparib Drugs Report Years Considered
Figure 10. Global Olaparib Drugs Sales 2017-2028 (K Pcs)
Figure 11. Global Olaparib Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Olaparib Drugs Revenue 2017-2028 (US$ Million)
Figure 13. Global Olaparib Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Olaparib Drugs Sales Market Share by Region (2017-2022)
Figure 15. Global Olaparib Drugs Sales Market Share by Region (2023-2028)
Figure 16. North America Olaparib Drugs Sales YoY (2017-2028) & (K Pcs)
Figure 17. North America Olaparib Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 18. Europe Olaparib Drugs Sales YoY (2017-2028) & (K Pcs)
Figure 19. Europe Olaparib Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Asia-Pacific Olaparib Drugs Sales YoY (2017-2028) & (K Pcs)
Figure 21. Asia-Pacific Olaparib Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Latin America Olaparib Drugs Sales YoY (2017-2028) & (K Pcs)
Figure 23. Latin America Olaparib Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Middle East & Africa Olaparib Drugs Sales YoY (2017-2028) & (K Pcs)
Figure 25. Middle East & Africa Olaparib Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 26. The Olaparib Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 27. The Top 5 and 10 Largest Manufacturers of Olaparib Drugs in the World: Market Share by Olaparib Drugs Revenue in 2021
Figure 28. Global Olaparib Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 29. Global Olaparib Drugs Sales Market Share by Type (2017-2028)
Figure 30. Global Olaparib Drugs Revenue Market Share by Type (2017-2028)
Figure 31. Global Olaparib Drugs Sales Market Share by Application (2017-2028)
Figure 32. Global Olaparib Drugs Revenue Market Share by Application (2017-2028)
Figure 33. North America Olaparib Drugs Sales Market Share by Type (2017-2028)
Figure 34. North America Olaparib Drugs Revenue Market Share by Type (2017-2028)
Figure 35. North America Olaparib Drugs Sales Market Share by Application (2017-2028)
Figure 36. North America Olaparib Drugs Revenue Market Share by Application (2017-2028)
Figure 37. North America Olaparib Drugs Sales Share by Country (2017-2028)
Figure 38. North America Olaparib Drugs Revenue Share by Country (2017-2028)
Figure 39. United States Olaparib Drugs Revenue (2017-2028) & (US$ Million)
Figure 40. Canada Olaparib Drugs Revenue (2017-2028) & (US$ Million)
Figure 41. Europe Olaparib Drugs Sales Market Share by Type (2017-2028)
Figure 42. Europe Olaparib Drugs Revenue Market Share by Type (2017-2028)
Figure 43. Europe Olaparib Drugs Sales Market Share by Application (2017-2028)
Figure 44. Europe Olaparib Drugs Revenue Market Share by Application (2017-2028)
Figure 45. Europe Olaparib Drugs Sales Share by Country (2017-2028)
Figure 46. Europe Olaparib Drugs Revenue Share by Country (2017-2028)
Figure 47. Germany Olaparib Drugs Revenue (2017-2028) & (US$ Million)
Figure 48. France Olaparib Drugs Revenue (2017-2028) & (US$ Million)
Figure 49. U.K. Olaparib Drugs Revenue (2017-2028) & (US$ Million)
Figure 50. Italy Olaparib Drugs Revenue (2017-2028) & (US$ Million)
Figure 51. Russia Olaparib Drugs Revenue (2017-2028) & (US$ Million)
Figure 52. Asia Pacific Olaparib Drugs Sales Market Share by Type (2017-2028)
Figure 53. Asia Pacific Olaparib Drugs Revenue Market Share by Type (2017-2028)
Figure 54. Asia Pacific Olaparib Drugs Sales Market Share by Application (2017-2028)
Figure 55. Asia Pacific Olaparib Drugs Revenue Market Share by Application (2017-2028)
Figure 56. Asia Pacific Olaparib Drugs Sales Share by Region (2017-2028)
Figure 57. Asia Pacific Olaparib Drugs Revenue Share by Region (2017-2028)
Figure 58. China Olaparib Drugs Revenue (2017-2028) & (US$ Million)
Figure 59. Japan Olaparib Drugs Revenue (2017-2028) & (US$ Million)
Figure 60. South Korea Olaparib Drugs Revenue (2017-2028) & (US$ Million)
Figure 61. India Olaparib Drugs Revenue (2017-2028) & (US$ Million)
Figure 62. Australia Olaparib Drugs Revenue (2017-2028) & (US$ Million)
Figure 63. China Taiwan Olaparib Drugs Revenue (2017-2028) & (US$ Million)
Figure 64. Indonesia Olaparib Drugs Revenue (2017-2028) & (US$ Million)
Figure 65. Thailand Olaparib Drugs Revenue (2017-2028) & (US$ Million)
Figure 66. Malaysia Olaparib Drugs Revenue (2017-2028) & (US$ Million)
Figure 67. Latin America Olaparib Drugs Sales Market Share by Type (2017-2028)
Figure 68. Latin America Olaparib Drugs Revenue Market Share by Type (2017-2028)
Figure 69. Latin America Olaparib Drugs Sales Market Share by Application (2017-2028)
Figure 70. Latin America Olaparib Drugs Revenue Market Share by Application (2017-2028)
Figure 71. Latin America Olaparib Drugs Sales Share by Country (2017-2028)
Figure 72. Latin America Olaparib Drugs Revenue Share by Country (2017-2028)
Figure 73. Mexico Olaparib Drugs Revenue (2017-2028) & (US$ Million)
Figure 74. Brazil Olaparib Drugs Revenue (2017-2028) & (US$ Million)
Figure 75. Argentina Olaparib Drugs Revenue (2017-2028) & (US$ Million)
Figure 76. Middle East and Africa Olaparib Drugs Sales Market Share by Type (2017-2028)
Figure 77. Middle East and Africa Olaparib Drugs Revenue Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Olaparib Drugs Sales Market Share by Application (2017-2028)
Figure 79. Middle East and Africa Olaparib Drugs Revenue Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Olaparib Drugs Sales Share by Country (2017-2028)
Figure 81. Middle East and Africa Olaparib Drugs Revenue Share by Country (2017-2028)
Figure 82. Turkey Olaparib Drugs Revenue (2017-2028) & (US$ Million)
Figure 83. Saudi Arabia Olaparib Drugs Revenue (2017-2028) & (US$ Million)
Figure 84. UAE Olaparib Drugs Revenue (2017-2028) & (US$ Million)
Figure 85. Olaparib Drugs Value Chain
Figure 86. Olaparib Drugs Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed


★調査レポート[オラパリブ薬の世界市場インサイト・予測（～2028年）] (コード：QY22JLX10431)販売に関する免責事項を必ずご確認ください。
★調査レポート[オラパリブ薬の世界市場インサイト・予測（～2028年）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 新型コロナウイルス感染症小分子薬の世界市場インサイト・予測（～2028年）
  • アレルギー治療薬の世界市場インサイト・予測（～2028年）
  • 血管収縮薬の世界市場インサイト・予測（～2028年）
  • 代謝性疾患治療薬の世界市場インサイト・予測（～2028年）
  • 免疫抑制薬の世界市場インサイト・予測（～2028年）

    • ◆H&Iグローバルリサーチのお客様（例）◆